University of Minnesota. Driven to Discover.
Peramivir, made by BioCryst, is intended to be given to influenza patients in a single intravenous dose.
The White House's $6.2 billion emergency Ebola funding request got its first hearing in Congress today.
The administration today asked Congress for $6.18 billion in emergency funds.
The $275 million deal will make the company the second leading player in the $4 billion global flu vaccine market.
Hospital executive faced tough questions from Congress about speed bumps in the response to the quickly evolving Ebola situation.
The multipronged attack includes an executive order, a national strategy, and a detailed PCAST report.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.